Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sanofi-Pasteur H5N1 Avian Flu Vaccine Stimulates Immune Response In Trial

This article was originally published in The Pink Sheet Daily

Executive Summary

The 300-subject study showed that a regimen of two 30 mcg doses with adjuvant was safe and well tolerated.

You may also be interested in...

EMEA Committee Agrees To Expedite Flu Vaccine Reviews

Accelerated review of flu vaccine “core dossiers” would allow approval within days of strain identification.

Sanofi-Pasteur Gets $100 Mil. HHS Contract to Make Avian Influenza Vaccine

The number of viable doses will depend upon the outcome of ongoing dosing studies, HHS says.

Tarceva Pancreatic Cancer Indication Turned Down In The EU

Roche will consider requesting a re-examination of the negative decision by the Committee for Medicinal Products for Human Use.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts